Metabolic conditions

Latest articles

The gut microbiome has captured the attention of both researchers and society, and important progress was made in 2019 in our understanding of its emerging role in health and disease. Although gut microbiome science is moving progressively from the bench to the bedside, much research in the field has looked at cataloguing the composition and function of gut microbial communities,…

GMFH Editing Team
GMFH Editing Team

The gut microbiome has captured the attention of both researchers and society, and important progress was made in 2019 in our understanding of its emerging role in health and disease. Although gut microbiome science is moving progressively from the bench to the bedside, much research in the field has looked at cataloguing the composition and function of gut microbial communities,…

GMFH Editing Team
GMFH Editing Team

Synbiotics are substances that combine a probiotic and prebiotic. While Gibson and Roberfroid were the first to anticipate that the two could be combined as synbiotics back in 1995, research in the field has accelerated over the past decade. The reported scientific literature on synbiotics includes a wide range of studies carried out under different conditions. Recent human trials have…

GMFH Editing Team
GMFH Editing Team

Synbiotics are substances that combine a probiotic and prebiotic. While Gibson and Roberfroid were the first to anticipate that the two could be combined as synbiotics back in 1995, research in the field has accelerated over the past decade. The reported scientific literature on synbiotics includes a wide range of studies carried out under different conditions. Recent human trials have…

GMFH Editing Team
GMFH Editing Team

Non-alcoholic fatty liver disease (NAFLD) is the main cause of chronic liver disease in developed countries. NAFLD often shares symptoms with other metabolic disorders such as type 2 diabetes and obesity. Recently, our gut microbiota has been revealed as a contributor to fatty liver disease development in both rodent models and NAFLD patients. However, the question of whether gut microbes…

GMFH Editing Team
GMFH Editing Team

Non-alcoholic fatty liver disease (NAFLD) is the main cause of chronic liver disease in developed countries. NAFLD often shares symptoms with other metabolic disorders such as type 2 diabetes and obesity. Recently, our gut microbiota has been revealed as a contributor to fatty liver disease development in both rodent models and NAFLD patients. However, the question of whether gut microbes…

GMFH Editing Team
GMFH Editing Team

Obesity and type 2 diabetes (T2D) have been associated with alterations in the gut microbiome. Given that both conditions are commonly manifested together and that ruling out the impact of external confounding factors in microbiome variation is a challenge, scientists struggle with teasing out gut microbiome hallmarks that uniquely characterize each of the two conditions. Louise Thingholm from Kiel University…

GMFH Editing Team
GMFH Editing Team

Obesity and type 2 diabetes (T2D) have been associated with alterations in the gut microbiome. Given that both conditions are commonly manifested together and that ruling out the impact of external confounding factors in microbiome variation is a challenge, scientists struggle with teasing out gut microbiome hallmarks that uniquely characterize each of the two conditions. Louise Thingholm from Kiel University…

GMFH Editing Team
GMFH Editing Team
Twitter
News archive
Access from here to the chronological archive of news of this site
Access archive
Latest articles

Obesity and type 2 diabetes (T2D) have been associated with alterations in the gut microbiome. Given that both conditions are commonly manifested together and that ruling out the impact of external confounding factors in microbiome…